Skip to main content

Table 4 EZ-ALBI and ALBI grade change after TACE

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Grade change (N = 142) EZ-ALBI, N (%) ALBI, N (%)
Improving grade 6 (4.2%) 6 (4.2%)
Same grade 94 (66.2%) 92 (64.8%)
Worsening grade 42 (29.6%) 44 (31.0%)
  1. ALBI Albumin-bilirubin, EZ-ALBI Easy albumin-bilirubin, N Number